Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 2101–2150 of 76231
Dr. Imoigele Aisiku, the Company’s co-Chief Executive Officer, was appointed as the sole Chief Executive Officer and the chairman of the board of directors of the Company, effective immediately.
effective June 3, 2026 Adam C. Spice will no longer serve as principal accounting officer.
On June 3, 2026, Rocket Lab Corporation (the “Company”) appointed Agostino Ricupati, age 59, as Vice President, Corporate Controller and Chief Accounting Officer and as the Company’s principal accounting officer.
Following Mr. Liu’s resignation, Mr. Yang Li serves as the sole Chief Executive Officer of the Company.
Henry Liu, who currently serves as one of the Company’s Co-Chief Executive Officers, provided notice to the Company of his resignation as Co-Chief Executive Officer, effective June 2, 2026.
On June 1, 2026, the Board approved an equity grant to Mr. McHugh with a grant date value substantially equivalent to that of the annual equity grants received by the Company’s continuing non-employee directors under the Non-Employee Director Compensation Policy on May 27, 2026, the date of our 2026 annual meeting of stockholders.
Eric Haynor, who currently serves as the Company’s Chief Operating Officer, provided notice to the Company of his resignation as Chief Operating Officer effective June 5, 2026.
On June 2, 2026, Terence J. Voskuil notified Woodward, Inc. of his intention to retire from his position as Executive Vice President, Chief Technology Officer, Aerospace, effective October 2, 2026 (the
Accordingly, effective as of the Separation Date, Ms. Greco will no longer serve as the Company’s Chief Commercial Officer.
Carrie D’Andrea will cease serving as Vice President of Clinical Operations of the Company and will no longer be employed by the Company effective June 5, 2026
appointed Thomas Lynch as a member of the Board, in each case effective as of June 2, 2026.
the Company announced that Arnaud Weber, the Company’s Engineering Lead, departed the Company on June 5, 2026.
On June 2, 2026, in connection with the IPO, John Salemi, Luis Pena Kegel, and Alfredo Flores Ibarrola (collectively, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
On June 2, 2026, in connection with the IPO, John Salemi, Luis Pena Kegel, and Alfredo Flores Ibarrola (collectively, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
On June 2, 2026, in connection with the IPO, John Salemi, Luis Pena Kegel, and Alfredo Flores Ibarrola (collectively, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
On June 3, 2026, Wilfred Daye resigned as a member of the board of directors (the “Board”) of Chaince Digital Holdings Inc. (the “Company”) and as Chief Strategy Officer of the Company, effective immediately.
On June 3, 2026, Mark A. Alexander notified the Board of Directors (the "Board") of Builders FirstSource, Inc. (the "Company") of his resignation from the Board, effective immediately, due to health reasons.
On June 2, 2026, John Christopher ("Chris") Shelton notified the Board of Directors (the "Board") of Fluence Energy, Inc. (the "Company") of his resignation from the Board, effective as of the close of business on June 3, 2026.
On June 3, 2026, the Board appointed Mr. Bernerd Da Santos as a director, effective as of the close of business on June 3, 2026, for a term expiring at the Company’s annual meeting of stockholders to be held in 2027
who the Company anticipates will be elevated into the CFO role upon Ms. Locklear’s departure (pending final contract).
On June 1, 2026, Ms. Lisa Locklear informed management of Longeveron Inc. (the “Company”) of her decision to step down as Chief Financial Officer, to become effective July 10, 2026.
On June 2, 2026, Alka Chaubey, Ph.D. resigned as Chief Medical Officer of Bionano Genomics, Inc. (the “Company”) effective July 5, 2026.
On June 1, 2026, the Board of Directors (the "Board") of AbCellera Biologics Inc. (the "Company") appointed Victor Sandor as a new director.
On June 2, 2026, Reid Hoffman, a member of the Board of Directors of Microsoft Corporation (the “Company”) since 2017, informed the Company of his decision not to stand for re-election at the Company’s 2026 annual shareholder meeting (the “Annual Meeting”).
the Board, at the recommendation of its nominating and governance committee, nominated each of Claire Bramley and David Lissy for election as a Class II director at the Annual Meeting.
As previously disclosed, Leela Srinivasan did not stand for re-election as a member of the board of directors
the Board, at the recommendation of its nominating and governance committee, nominated each of Claire Bramley and David Lissy for election as a Class II director at the Annual Meeting.
Anilu Vazquez-Ubarri resigned from the Board effective immediately prior to the election of directors at the Annual Meeting.
the Board appointed Greg Deisher , who is currently a Senior Vice President of the Company, to serve the Chief Operating Officer and Executive Vice President filling the vacancy created by the previous resignation of Ms. Janice K. Smith.
the Board appointed Mark Tubinis , who is currently the Chief Commercial Officer of the Company, to also serve as an Executive Vice President.
Effective June 1, 2026, the Board of Directors (the “Board”) of Satellogic Inc. (the “Company”) increased the size of the Board from seven directors to eight directors and appointed Michael E. Williamson to fill the vacancy as a Class III Director.
the Board appointed Dr. John David Yee and Mr. William Drake Richey as Class II directors to fill vacancies on the Board.
the Board of Directors of the Company (the “Board”) appointed Mr. Justin Trojanowski as Vice President, Finance, Principal Financial Officer and Corporate Secretary of the Company, in addition to his current role as Corporate Controller, Treasurer and Principal Accounting Officer of the Company.
the Board appointed Dr. John David Yee and Mr. William Drake Richey as Class II directors to fill vacancies on the Board.
Mr. Nicholas Maestas notified Tempest Therapeutics, Inc. (the “Company”) of his decision to resign from his position as Chief Financial Officer of the Company and from any and all other positions he holds with the Company, effective as of June 5, 2026.
On June 3, 2026, the Board of Directors (the “Board”) of Direct Digital Holdings, Inc. (the “Company”) appointed Ohad Harlev to serve as an Independent Director on its Board, effective immediately, and increased the size of its Board in connection with his appointment.
On June 4, 2026, the Board of Directors of The Baldwin Insurance Group, Inc. (the “Company”) appointed Johnathan Daniel to serve as interim Chief Accounting Officer of the Company effective upon the commencement of Corbyn Lichon’s, the Company’s Chief Accounting Officer, maternity leave, which is expected to begin in mid-to-late June 2026.
On June 3, 2026, Mr. Kevin Knight resigned as Executive Chairman of the Board of Directors (the “Board”) and member of the Board of Knight-Swift Transportation Holdings Inc. (the “Company”), effective June 3, 2026 (the “Effective Date”).
The Board appointed David Vander Ploeg as Chair of the Board effective upon Mr. Knight’s resignation.
On June 4, 2026, Yilin Lu resigned from his position as the President and a member of the Board of Directors of LQR House Inc. (the “ Company ”), effective immediately.
On May 29, 2026, the Company and the Bank appointed Angela Krezmer (age 40) to succeed Mr. Fazio as Executive Vice President and Chief Financial Officer effective July 1, 2026.
In addition, on May 29, 2026, the Company and the Bank appointed Angelo Testani to the position of Executive Vice President and Chief Banking Officer.
On May 29, 2026, Vincent Fazio notified Seneca Bancorp, Inc. (the “Company”) and its bank subsidiary, Seneca Savings Bank, National Association (the “Bank”), that he intends to retire as the Company’s and the Bank’s Executive Vice President and Chief Financial Officer effective at the close of business on June 30, 2026.
Michael L. Perkins informed the Board of Directors of Wesbanco, Inc. (the “Company”) that Mr. Perkins will retire from his position as the Company’s Senior Executive Vice President and Chief Risk Officer, effective June 30, 2026.
appointed Shelley Bausch to serve as a Class II director of the Company starting as of July 1, 2026
On June 3, 2026, the board of directors of Avalon GloboCare Corp. (the “Company”) appointed Luisa Ingargiola as the Company’s Chief Strategy Officer, and Sam Knipper as the Company’s Chief Financial Officer, in each case, effective June 3, 2026 (the “Effective Date”).
On June 3, 2026, the board of directors of Avalon GloboCare Corp. (the “Company”) appointed Luisa Ingargiola as the Company’s Chief Strategy Officer, and Sam Knipper as the Company’s Chief Financial Officer, in each case, effective June 3, 2026 (the “Effective Date”).
On June 1, 2026, Kathryn Gregory notified Longevity Health Holdings, Inc. (the “Company”) of her resignation from the Board of Directors of the Company, effective as of the close of business on June 1, 2026.
On May 29, 2026, Bally’s Management Group, LLC, a subsidiary of Bally’s Corporation, entered into an employment agreement with Cheryl Ash, as its Senior Vice President, Finance and North America, as well as the Chief Financial Officer of Bally’s Chicago.
Mr. Surran will succeed Jay Geldmacher, who will transition to an executive advisor role and will resign from the Board following the appointment of Mr. Surran upon consummation of the ADI Spin-Off Transaction, pursuant to the terms of a previously announced transition arrangement.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.